Henry Schein, Inc.  

(Public, NASDAQ:HSIC)   Watch this stock  
Find more results for HSIC
96.59
-1.56 (-1.59%)
Jun 19 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 96.51 - 98.18
52 week 72.84 - 98.28
Open 97.90
Vol / Avg. 247,423.00/391,063.00
Mkt cap 8.42B
P/E 21.69
Div/yield     -
EPS 4.45
Shares 87.13M
Beta 0.78
Inst. own 95%
Jul 29, 2013
Q2 2013 Henry Schein Earnings Release Add to calendar
Jun 19, 2013
Henry Schein at Wells Fargo Health Care Conference - Webcast
Jun 13, 2013
Henry Schein at Goldman Sachs Healthcare Conference - Webcast
Jun 12, 2013
Henry Schein at William Blair Growth Stock Conference - Webcast
Jun 5, 2013
Henry Schein at Jefferies Global Healthcare Conference - Webcast
May 30, 2013
Henry Schein at Deutsche Bank dbAccess Health Care Conference - Webcast
May 29, 2013
Henry Schein at Stifel Dental and Veterinary Conference
May 21, 2013
Henry Schein at UBS Global Healthcare Conference - Webcast
May 14, 2013
Henry Schein Annual Shareholder Meeting
May 7, 2013
Q1 2013 Henry Schein Earnings Conference Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 4.27% 4.66%
Operating margin 6.70% 6.92%
EBITD margin - 8.50%
Return on average assets 7.45% 8.27%
Return on average equity 14.13% 15.38%
Employees 15,000 -
Carbon Disclosure Rating - -

Address

135 Duryea Road
MELVILLE, NY 11747
United States - Map
+1-631-8435500 (Phone)
+1-631-8435658 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Henry Schein, Inc. is a provider of health care products and services to office-based practitioners. The Company conducts its business through two segments: healthcare distribution and technology. The healthcare distribution segment aggregates its dental, medical, animal health and international operating segments. Its technology group provides software, technology and other services to healthcare practitioners, primarily in the United States, Canada, the United Kingdom, Australia and New Zealand. In April 2012, Biolase Technology, Inc. purchased 159 Waterlase MD Turbo laser systems from the Company. On May 24, 2012, it acquired AUV Veterinary Services B.V. In July 2012, it announced three acquisitions, which include Ortho Technology, Inc., Modern Laboratory Services and Accord. In September 2012, the Company acquired a majority interest in The Exan Group (Exan). In December 2012, the Company acquired C&M Vetlink. Effective February 18, 2013, the Company acquired Maddox Practice Group.

Officers and directors

Stanley M. Bergman Chairman of the Board, Chief Executive Officer
Age: 63
Bio & Compensation  - Reuters
James P. Breslawski President, Chief Operating Officer, Director; Chief Executive Officer of Henry Schein Global Dental Group
Age: 59
Bio & Compensation  - Reuters
Steven Paladino Chief Financial Officer, Executive Vice President, Director
Age: 55
Bio & Compensation  - Reuters
Lonnie Shoff President and Chief Executive Officer of Global Animal Health and Strategic Partnerships Group
Age: 54
Bio & Compensation  - Reuters
Michael Zack President - International Group
Age: 60
Bio & Compensation  - Reuters
Gerald A. Benjamin Chief Administrative Officer, Executive Vice President, Director
Bio & Compensation  - Reuters
Mark E. Mlotek Chief Strategic Officer, Executive Vice President, Director
Age: 57
Bio & Compensation  - Reuters
James A. Harding Chief Technology Officer, Senior Vice President
Bio & Compensation  - Reuters
Leonard A. David Chief Compliance Officer, Senior Vice President
Age: 64
Bio & Compensation  - Reuters
Michael Racioppi Senior Vice President, Chief Merchandising Officer
Age: 58
Bio & Compensation  - Reuters